1. Introduction
1.1 Report Guidance
1.2 Market Segmentation
2. Executive Summary
2.1 Key Market Insights
2.2 Market Attractiveness
3. Research Methodology
3.1 Secondary Research
3.2 Primary Research
- 3.2.1 Data Triangulation and Validation
4. North America Cartilage Degeneration Market Landscape
4.1 Overview
4.3 Ecosystem Analysis
- 4.3.1 List of Vendors in the Value Chain
5. North America Cartilage Degeneration Market – Key Market Dynamics
5.1 Market Drivers
5.2 Market Restraints
5.3 Market Opportunities
5.4 Future Trends
5.5 Impact of Drivers and Restraints
6. North America Cartilage Degeneration Market Regional Analysis
6.2 North America Cartilage Degeneration Market Revenue 2017-2027 (US$ Million)
6.3 North America Cartilage Degeneration Market Forecast Analysis
7. North America Cartilage Degeneration Market Analysis – by Procedure Type
7.1 Osteochondral Transplant
- 7.1.1 Overview
- 7.1.2 Osteochondral Transplant: North America Cartilage Degeneration Market – Revenue and Forecast, 2017-2027 (US$ Million)
7.2 Chondroplasty
- 7.2.1 Overview
- 7.2.2 Chondroplasty: North America Cartilage Degeneration Market – Revenue and Forecast, 2017-2027 (US$ Million)
7.3 Joint Replacement
- 7.3.1 Overview
- 7.3.2 Joint Replacement: North America Cartilage Degeneration Market – Revenue and Forecast, 2017-2027 (US$ Million)
7.4 Meniscus Transplants
- 7.4.1 Overview
- 7.4.2 Meniscus Transplants: North America Cartilage Degeneration Market – Revenue and Forecast, 2017-2027 (US$ Million)
7.5 Cell-based Cartilage Resurfacing
- 7.5.1 Overview
- 7.5.2 Cell-based Cartilage Resurfacing: North America Cartilage Degeneration Market – Revenue and Forecast, 2017-2027 (US$ Million)
8. North America Cartilage Degeneration Market Analysis – by Application
8.1 Knee
- 8.1.1 Overview
- 8.1.2 Knee: North America Cartilage Degeneration Market – Revenue and Forecast, 2017-2027 (US$ Million)
8.2 Hips
- 8.2.1 Overview
- 8.2.2 Hips: North America Cartilage Degeneration Market – Revenue and Forecast, 2017-2027 (US$ Million)
9. North America Cartilage Degeneration Market Analysis – by End User
9.1 Hospitals & Specialty Clinics
- 9.1.1 Overview
- 9.1.2 Hospitals & Specialty Clinics: North America Cartilage Degeneration Market – Revenue and Forecast, 2017-2027 (US$ Million)
9.2 Ambulatory Surgical Centers
- 9.2.1 Overview
- 9.2.2 Ambulatory Surgical Centers: North America Cartilage Degeneration Market – Revenue and Forecast, 2017-2027 (US$ Million)
9.3 Academic & Research Institutes
- 9.3.1 Overview
- 9.3.2 Academic & Research Institutes: North America Cartilage Degeneration Market – Revenue and Forecast, 2017-2027 (US$ Million)
10. North America Cartilage Degeneration Market – North America Analysis
10.1 Overview
10.2 North America
- 10.2.1 North America Cartilage Degeneration Market Breakdown, by Key
Country, 2020 and 2027 (%)
- 10.2.1.1 North America Cartilage Degeneration Market – Revenue and
Forecast Analysis – by Country
- 10.2.1.1 US:
North America Cartilage Degeneration Market – Revenue and Forecast to 2027 (US$ Million)
- 10.2.1.1.1 US: North America Cartilage Degeneration Market Breakdown, by Procedure Type
- 10.2.1.1.2 US: North America Cartilage Degeneration Market Breakdown, by Application
- 10.2.1.1.3 US: North America Cartilage Degeneration Market Breakdown, by End User
- 10.2.1.2 Canada:
North America Cartilage Degeneration Market – Revenue and Forecast to 2027 (US$ Million)
- 10.2.1.2.1 Canada: North America Cartilage Degeneration Market Breakdown, by Procedure Type
- 10.2.1.2.2 Canada: North America Cartilage Degeneration Market Breakdown, by Application
- 10.2.1.2.3 Canada: North America Cartilage Degeneration Market Breakdown, by End User
- 10.2.1.3 Mexico :
North America Cartilage Degeneration Market – Revenue and Forecast to 2027 (US$ Million)
- 10.2.1.3.1 Mexico : North America Cartilage Degeneration Market Breakdown, by Procedure Type
- 10.2.1.3.2 Mexico : North America Cartilage Degeneration Market Breakdown, by Application
- 10.2.1.3.3 Mexico : North America Cartilage Degeneration Market Breakdown, by End User
11. Competitive Landscape
11.1 Heat Map Analysis
11.2 Company Positioning and Concentration
12. Industry Landscape
12.1 Overview
12.2 Market Initiative
12.3 Partnerships and Collaborations
12.4 Other Developments
13. Company Profiles
13.1 Zimmer Biomet
- 13.1.1 Key Facts
- 13.1.2 Business Description
- 13.1.3 Products and Services
- 13.1.4 Financial Overview
- 13.1.5 SWOT Analysis
- 13.1.6 Key Developments
13.2 Stryker Corporation
- 13.2.1 Key Facts
- 13.2.2 Business Description
- 13.2.3 Products and Services
- 13.2.4 Financial Overview
- 13.2.5 SWOT Analysis
- 13.2.6 Key Developments
13.3 Johnson and Johnson Services, Inc.
- 13.3.1 Key Facts
- 13.3.2 Business Description
- 13.3.3 Products and Services
- 13.3.4 Financial Overview
- 13.3.5 SWOT Analysis
- 13.3.6 Key Developments
13.4 CONMED Corporation
- 13.4.1 Key Facts
- 13.4.2 Business Description
- 13.4.3 Products and Services
- 13.4.4 Financial Overview
- 13.4.5 SWOT Analysis
- 13.4.6 Key Developments
13.5 Arthrex, Inc.
- 13.5.1 Key Facts
- 13.5.2 Business Description
- 13.5.3 Products and Services
- 13.5.4 Financial Overview
- 13.5.5 SWOT Analysis
- 13.5.6 Key Developments
13.6 Anika Therapeutics, Inc.
- 13.6.1 Key Facts
- 13.6.2 Business Description
- 13.6.3 Products and Services
- 13.6.4 Financial Overview
- 13.6.5 SWOT Analysis
- 13.6.6 Key Developments
14. Appendix
14.1 About Business Market Insights
14.2 List of Abbreviations
Get Free Sample For North America Cartilage Degeneration Market
